Tumor-agnostic multimodal cell-free DNA analysis improves detection and enables longitudinal disease monitoring in esophageal adenocarcinoma
This study demonstrates that a tumor-agnostic, multimodal cell-free DNA framework integrating genomic, copy-number, and fragmentomic features significantly improves detection and enables accurate longitudinal disease monitoring and mortality risk prediction in esophageal adenocarcinoma patients.